Xeris Biopharma Holdings, Inc. Common Stock XERS

$16.62 -2.18% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-11-06 View →
10-Q 10-Q 2026-11-05 View →
8-K 8-K 2026-11-05 View →
4 FORM 4 2026-11-04 View →
4 FORM 4 2026-11-04 View →
4 FORM 4 2026-11-04 View →
4 FORM 4 2026-11-04 View →
8-K 8-K 2026-11-02 View →
8-K 8-K 2026-10-14 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-09-29 View →
8-K 8-K 2026-09-09 View →
4 FORM 4 2026-09-01 View →
4 FORM 4 2026-09-01 View →
4 FORM 4 2026-09-01 View →
4 FORM 4 2026-08-21 View →
4 FORM 4 2026-08-21 View →
4 FORM 4 2026-08-12 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
4 FORM 4 2026-08-04 View →
4 FORM 4 2026-08-04 View →
8-K 8-K 2026-07-17 View →
4 FORM 4 2026-07-07 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-02 View →
4 FORM 4 2026-07-02 View →
8-K 8-K 2026-06-30 View →
8-K 8-K 2026-06-11 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
8-K 8-K 2026-06-05 View →
4 FORM 4 2026-06-02 View →
10-Q 10-Q 2026-05-07 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$16.62
Market Cap
$3.04 billion
52-Week Range
$5.25 – $17.28
Average Volume
3.10 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.